| 产品详情 |
| Edit |   |
|---|
| Product Name | Capecitabine (5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978, Xeloda) |
|---|
| Description | Purity ~99%. Capecitabine is a pre-prodrug of 5-fluorouracil (5-FU). After oral uptake, capecitabine is first metabolized to 5'-deoxy-5-fluorocytidine (5'-DFCR), which happens mainly in the liver by carboxyl-esterase. The metabolite is converted to 5'-deoxy-5-fluoro-uridine (5'-DFUR) by cytidine deaminase in liver and tumor tissue. Then 5'-DFUR is converted to 5-FU intracellularly by thymidine phosphorylase, which is often expressed in tumor tissue. Solubility: Soluble in DMSO at 100mg/ml; soluble in ethanol at 12.5mg/ml with slight warming; soluble in water at 2mg/ml with slight warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
|---|
| Size | 500mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | C1077-05B |
|---|
| Price | |
|---|
| Order / More Info | Capecitabine (5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978, Xeloda) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|